Genmab A (GMAB) Current Assets (2023 - 2026)
Genmab A's Current Assets was $2.8 billion in the quarter ended Jun 30, 2026, up 8.9% from the prior quarter.
Analysis
Genmab A (GMAB) Current Assets (2023 - 2026) Analysis & Trends
As of Dec 31, 2025, Current Assets at Genmab A came in at $2.89 billion, down 26.0% from the prior year.
- Current Assets shows a five-year compound annual growth rate of 5.7% (years ended Dec 2020 to Dec 2025).
- In earlier years, Current Assets was $3.9 billion in the year ended Dec 31, 2024 (-20.6%), $4.91 billion in the year ended Dec 31, 2023 (+86.5%), $2.63 billion in the year ended Dec 31, 2022 (+2.5%) and $2.57 billion in the year ended Dec 31, 2021 (+17.7%).
- Quarterly Current Assets has moved between $691.93 million (the quarter ended Sep 30, 2025) and $4.05 billion (the quarter ended Jan 1, 2023) over five years.
- Compared with a year earlier, Current Assets was higher in two of the last four quarters, with growth averaging 3.8%.
- The best year-over-year quarter for Current Assets over five years was the quarter ended Jun 30, 2025 (growth of 90.4%); the worst was the quarter ended Sep 30, 2021 (a decline of 87.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Genmab A | 2.56 Bn | -2.81 Bn | 1.07 Bn | 2.80 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.80 Bn |
| Mar 31, 2026 | 2.57 Bn |
| Dec 31, 2025 | 2.89 Bn |
| Sep 30, 2025 | 691.93 Mn |
| Jun 30, 2025 | 3.91 Bn |
| Mar 31, 2025 | 4.04 Bn |
| Dec 31, 2024 | 3.90 Bn |
| Dec 31, 2023 | 4.91 Bn |
| Jan 1, 2023 | 4.05 Bn |
API Access
Genmab A Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=GMAB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "GMAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=GMAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();